hydralazine has been researched along with Cardiomyopathies in 16 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "25 mg/kg hydralazine were studied during cardiac catheterisation of 9 patients with primary congestive cardiomyopathy and heart failure." | 3.66 | [Hemodynamic effects of hydralazine in the cardiac insufficiency of non-obstructive myocardiopathy]. ( Datchary, J; Fernandez, F; Gerbaux, A; Gras, H; Lelguen, C; Pailloncy, M; Ponsonnaille, J, 1979) |
| " Changes in hydrazinophthalazine-treated rats after dosing them with isoprenaline had a similar tendency but they were significantly lower than those found in healthy animals receiving isoprenaline only." | 1.27 | Effect of isoprenaline on tissue elastin content and serum elastolytic activity in normal and hydrazinophthalazine-treated rats. ( Drózdz, M; Kucharz, E; Olczyk, K; Wieczorek, M, 1987) |
| "A 23-year-old woman with systemic lupus erythematosus was found to have severe pulmonary hypertension with secondary patency of the foramen ovale." | 1.27 | Danger of vasodilator therapy for pulmonary hypertension in patent foramen ovale. ( Girard, P; Laine, JF; Motté, G; Petitpretz, P; Slama, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (87.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levine, TB | 1 |
| Levine, AB | 1 |
| Bolenbaugh, J | 1 |
| Green, PR | 1 |
| Drózdz, M | 2 |
| Piwowarczyk, B | 1 |
| Olczyk, K | 2 |
| Wieczorek, M | 2 |
| Wróblewska-Adamek, I | 1 |
| Artman, M | 1 |
| Parrish, MD | 1 |
| Graham, TP | 1 |
| Rouleau, JL | 1 |
| Chuck, LH | 1 |
| Hollosi, G | 1 |
| Kidd, P | 1 |
| Sievers, RE | 1 |
| Wikman-Coffelt, J | 1 |
| Parmley, WW | 1 |
| Fernandez, F | 2 |
| Sprogis, W | 1 |
| Baclet, M | 1 |
| Lelguen, C | 2 |
| Gerbaux, A | 2 |
| Serbin, VI | 1 |
| Gasanova, AS | 1 |
| Balazs, T | 2 |
| Ferrans, VJ | 1 |
| El-Hage, A | 1 |
| Ehrreich, SJ | 1 |
| Johnson, GL | 1 |
| Herman, EH | 1 |
| Atkinson, JC | 1 |
| West, WL | 1 |
| Heer, KR | 1 |
| Davies, J | 1 |
| MacArthur, CG | 1 |
| Das, SK | 1 |
| Randall, OS | 1 |
| Steffens, TG | 1 |
| Ferreira, C | 2 |
| Murad, N | 1 |
| Póvoa, R | 1 |
| Luna, B | 1 |
| Simões, Mde J | 1 |
| Mora, OA | 1 |
| Ferreira, M | 1 |
| Pailloncy, M | 1 |
| Datchary, J | 1 |
| Ponsonnaille, J | 1 |
| Gras, H | 1 |
| Figulla, HR | 1 |
| Vetterlein, F | 1 |
| Glaubitz, M | 1 |
| Kreuzer, H | 1 |
| Joseph, X | 1 |
| Rosenbaum, JS | 1 |
| Ginsburg, R | 1 |
| Billingham, ME | 1 |
| Hoffman, BB | 1 |
| Kucharz, E | 1 |
| Laine, JF | 1 |
| Slama, M | 1 |
| Petitpretz, P | 1 |
| Girard, P | 1 |
| Motté, G | 1 |
2 reviews available for hydralazine and Cardiomyopathies
| Article | Year |
|---|---|
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Ele | 1983 |
[Peripheral vasodilators in the treatment of heart failure].
Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazi | 1982 |
14 other studies available for hydralazine and Cardiomyopathies
| Article | Year |
|---|---|
Reversal of heart failure remodeling: is it maintained?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiomyopathies; Echocardiography; Female | 2003 |
Leukocyte collagenolytic activity in normal and hydrazinophthalazine-treated rats during isoprenaline-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Cathepsins; Collagen; Hydralazine; Isoproterenol; Leukocytes; Macrophages | 1983 |
Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster.
Topics: Actins; Adenosine Triphosphatases; Animals; Cardiomyopathies; Cricetinae; Digoxin; Hydralazine; Meso | 1982 |
[Study of the effects on coronary circulation and myocardial metabolism of a single intravenous dose of dihydralazine in 10 cases of primary myocardiopathy].
Topics: Adult; Blood Pressure; Cardiomyopathies; Coronary Circulation; Dihydralazine; Female; Heart Rate; Hu | 1980 |
Study of the mechanism of hydralazine-induced myocardial necrosis in the rat.
Topics: Animals; Calcium; Cardiomyopathies; Dihydrotachysterol; Heart Rate; Hydralazine; Male; Necrosis; Pro | 1981 |
The effect of hydralazine on arrhythmias in congestive cardiomyopathy.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathies; Female; Heart Failure; Heart Ra | 1981 |
Ventricular wall thickness: a predictor of response to vasodilators in cardiomyopathy.
Topics: Administration, Oral; Adult; Cardiomyopathies; Follow-Up Studies; Heart Ventricles; Hemodynamics; Hu | 1980 |
[A myocardial lesion induced by hydralazine].
Topics: Adrenal Glands; Analysis of Variance; Animals; Antihypertensive Agents; Cardiomyopathies; Heart; His | 1995 |
[Hemodynamic effects of hydralazine in the cardiac insufficiency of non-obstructive myocardiopathy].
Topics: Adult; Cardiomyopathies; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged | 1979 |
Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster.
Topics: Animals; Capillaries; Cardiomyopathies; Cricetinae; Female; Hydralazine; Male; Mesocricetus; Myocard | 1987 |
Enhanced myocardial necrosis induced in rats by the combined administration of hydralazine and prenalterol.
Topics: Adrenergic beta-Antagonists; Animals; Cardiomyopathies; Drug Interactions; Hydralazine; Male; Myocar | 1986 |
Effects of adrenergic receptor antagonists on cardiac morphological and functional alterations in rats harboring pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cardiom | 1987 |
Effect of isoprenaline on tissue elastin content and serum elastolytic activity in normal and hydrazinophthalazine-treated rats.
Topics: Animals; Cardiomyopathies; Collagen Diseases; Elastin; Hydralazine; Isoproterenol; Male; Pancreatic | 1987 |
Danger of vasodilator therapy for pulmonary hypertension in patent foramen ovale.
Topics: Adult; Blood Pressure; Cardiomyopathies; Female; Heart Septum; Humans; Hydralazine; Hypertension, Pu | 1986 |